Strange Geoff, Stewart Simon, Playford David, Strom Jordan B
Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Institute of Health Research, University of Notre Dame, Fremantle, Australia; Heart Research Institute, Sydney, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
Institute of Health Research, University of Notre Dame, Fremantle, Australia; School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, United Kingdom.
J Am Soc Echocardiogr. 2023 Jan;36(1):60-68.e2. doi: 10.1016/j.echo.2022.09.020. Epub 2022 Oct 5.
Aortic stenosis (AS) is the most common valvular heart disease in high-income countries. Adjusted for clinical confounders, the risk associated with increasing AS severity across the spectrum of AS severity remains uncertain.
The authors conducted an international, multicenter, parallel-cohort study of 217,599 Australian (mean age, 76.0 ± 7.3 years; 49.3% women) and 30,865 US (mean age, 77.4 ± 7.3 years; 52.2% women) patients aged ≥65 years who underwent echocardiography. Patients with previous aortic valve replacement were excluded. The risk of increasing AS severity, quantified by peak aortic velocity (Vmax), was assessed through linkage to 97,576 and 14,481 all-cause deaths in Australia and the United States, respectively.
The distribution of AS severity (mean Vmax, 1.7 ± 0.7 m/sec) was similar in both cohorts. Compared with those with Vmax of 1.0 to 1.49 m/sec, those with Vmax of 2.50 to 2.99 m/sec (US cohort) or Vmax of 3.0 to 3.49 m/sec (Australian cohort) had a 1.5-fold increase in mortality risk within 10 years, adjusting for age, sex, presence of left heart disease, and left ventricular ejection fraction. Overall, the adjusted risk for mortality plateaued (1.75- to 2.25-fold increased risk) above a Vmax of 3.5 m/sec. This pattern of mortality persisted despite adjustment for a comprehensive list of comorbidities and treatments within the US cohort.
Within large, parallel patient cohorts managed in different health systems, similar patterns of mortality linked to increasingly severe AS were observed. These findings support ongoing clinical trials of aortic valve replacement in patients with nonsevere AS and suggest the need to develop and apply more proactive surveillance strategies in this high-risk population.
在高收入国家,主动脉瓣狭窄(AS)是最常见的心脏瓣膜疾病。校正临床混杂因素后,整个AS严重程度范围内,与AS严重程度增加相关的风险仍不确定。
作者对217,599名澳大利亚患者(平均年龄76.0±7.3岁;49.3%为女性)和30,865名美国患者(平均年龄77.4±7.3岁;52.2%为女性)进行了一项国际多中心平行队列研究,这些患者年龄≥65岁,均接受了超声心动图检查。排除既往有主动脉瓣置换术的患者。通过与澳大利亚和美国分别的97,576例和14,481例全因死亡病例进行关联,评估以主动脉峰值流速(Vmax)量化的AS严重程度增加的风险。
两个队列中AS严重程度的分布(平均Vmax,1.7±0.7米/秒)相似。与Vmax为1.0至1.49米/秒的患者相比,Vmax为2.50至2.99米/秒(美国队列)或Vmax为3.0至3.49米/秒(澳大利亚队列)的患者在10年内死亡风险增加1.5倍,校正了年龄、性别、左心疾病的存在情况和左心室射血分数。总体而言,Vmax高于3.5米/秒时,校正后的死亡风险趋于平稳(风险增加1.75至2.25倍)。在美国队列中,尽管对一系列合并症和治疗进行了校正,但这种死亡模式仍然存在。
在不同卫生系统管理的大型平行患者队列中,观察到与AS日益严重相关的相似死亡模式。这些发现支持对非严重AS患者进行主动脉瓣置换的正在进行的临床试验,并表明需要在这一高风险人群中制定和应用更积极的监测策略。